Emmaus Life Sciences's total assets for Q1 2025 were $22.48M, a decrease of -4.76% from the previous quarter. EMMA total liabilities were $81.08M for the fiscal quarter, a 1.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.